AMA Journal of Ethics®

Illuminating the art of medicine

Journal of Ethics Header

AMA Journal of Ethics®

Illuminating the art of medicine

Virtual Mentor. April 2009, Volume 11, Number 4: 345-347.


  • Print
  • |
  • View PDF

About the Contributors

Theme issue: Ethics in Clinical Research

Theme Issue Editor

Babak J. Orandi, MD, MSc, is a first-year general surgery resident at the Johns Hopkins Hospital in Baltimore. A former Fulbright fellow and a past fellow of the NIHís Clinical Research Training Program, he received his undergraduate, medical, and masterís (in clinical research) degrees from the University of Michigan.


Emily Abdoler is a predoctoral fellow in the Department of Bioethics, Clinical Center of the National Institutes of Health in Bethesda, Maryland. She received a bachelor of arts degree in molecular biology and bioethics from William Jewell College and will begin medical school in fall 2009.

Rebecca Dresser, JD, is the Daniel Noyes Kirby Professor of Law and professor of ethics in medicine at Washington University in St. Louis. Since 1983, she has taught medical and law students about legal and ethical issues in end-of-life care, biomedical research, genetics, assisted reproduction, and related topics. She has been a member of the Presidentís Council on Bioethics since 2002.

Julie Freischlag, MD, is the William Stewart Halsted Professor and chair of the Department of Surgery and surgeon-in-chief at the Johns Hopkins Hospital in Baltimore. Before 2003, she was chief of the Vascular Surgery Division and director of the Gonda (Goldschmied) Vascular Center at UCLA, where she also completed her surgical residency and post-residency vascular fellowship. Dr. Freischlag is the editor of the Archives of Surgery, has published more than 150 manuscripts and numerous abstracts and book chapters, and serves on several editorial boards.

Mark T. Hughes, MD, MA, is an assistant professor of medicine in the Division of General Internal Medicine and a core faculty member of the Berman Institute of Bioethics at the Johns Hopkins University School of Medicine in Baltimore. His research interests include advance-care planning, end-of-life decision making, everyday ethics, professionalism, and research ethics. He is the director of CORE, a mandatory course on research ethics for all faculty and fellows who conduct human-subjects research. Dr. Hughes is codeveloper and associate editor of the Internet Learning Center, an Internet-based curriculum used by medical residency programs.

Felix Khin-Maung-Gyi, PharmD, MBA, is founder and CEO of the Chesapeake Research Review and an expert in the area of human-subject protection both in the United States and abroad. Dr. Gyi was appointed as a charter member of the Secretaryís Committee on Human Research Protections (SACHRP) of the U.S. Department of Health and Human Services in 2003, and is currently a member of a subcommittee of SACHRP designated to review the interpretations and impact of regulations on the burdens and efficiencies of human-research protections. Dr. Gyi is coauthor of Ethics of the Use of Human Subjects in Research, chapters in other books, and articles in DIA Journal, Applied Clinical Trials, and Research Practitioner.

Akhil Mehra, MD, MPhil,, is an assistant clinical professor of psychiatry and a PhD candidate in the Department of History, Anthropology, and Social Medicine at the University of California, San Francisco.

Margaret R. Moon, MD, MPH, is the Freeman Family Scholar in Clinical Medical Ethics in the Berman Institute of Bioethics at Johns Hopkins University in Baltimore. She is also an assistant professor in the Division of Pediatrics and Adolescent Medicine at Johns Hopkins University School of Medicine.

Micah R. Onixt, JD, is an attorney at DLA Piper in Chicago. He concentrates his practice on the areas of life sciences and information technology with an emphasis on corporate and securities, venture capital, licensing, and intellectual property, particularly patent prosecution. Mr. Onixt has worked with and helped numerous pharmaceutical companies, life-science companies, and medical professionals with respect to clinical-trial practice.

Chandra Y. Osborn, PhD, MPH, is an assistant professor of medicine and a research investigator at the Center for Health Services Research in the Division of General Internal Medicine & Public Health and the Eskind Diabetes Center at Vanderbilt University in Nashville, Tennessee. Dr. Osborn received an MA and PhD in social/health psychology and a graduate certificate in quantitative research methods from the University of Connecticut. She was a health-services research fellow at Northwestern University Feinberg School of Medicine, where she also completed a masterís degree in public health. Her research focuses on understanding population-specific determinants of health-behavior change and on testing frameworks to inform the design and content of tailored health-promotion interventions for chronically ill patients.

Timothy M. Pawlik, MD, MPH, is an associate professor of surgery and oncology at Johns Hopkins University School of Medicine in Baltimore. In addition to completing his residency at the University of Michigan and a surgical oncology fellowship at the University of Texas M. D. Anderson Cancer Center, Dr. Pawlik attended Harvard Divinity School, where he obtained a masterís degree in theological studies. Dr. Pawlik is the hepatobiliary surgery program director, and his research interests include clinical trials and outcomes for HPB malignancies.

Amanda Redig is an MD/PhD student at Northwestern Universityís Feinberg School of Medicine in Chicago. She will defend her doctoral thesis in April 2009 and graduate from medical school in May 2010, at which time she plans to pursue a career in academic hematology-oncology. As a research scientist, future physician, and prior patient-research subject, Ms. Redig is committed to clinical research that is medically exciting and ethically sound.

Garrett M. Sparks, MD, MS, is a resident in psychiatry at the Western Psychiatric Institute and Clinic at the University of Pittsburgh Medical Center. His research interests include phenomenology and psychosocial interventions in pediatric bipolar disorder, ADHD, and substance abuse.

Robyn L. Sterling, JD, MPH, is an attorney at DLA Piper in Chicago, and focuses her practice on health care pertaining to corporate, regulatory, and litigation matters, as well as life sciences. Ms. Sterling worked for the federal government, where she concentrated on the Food and Drug Administrationís oversight of clinical trials, drugs, and medical devices.